HomeROVI • BME
add
Laboratorios Farmaceuticos ROVI SA
Previous close
€53.20
Day range
€51.35 - €53.35
Year range
€51.35 - €94.80
Market cap
2.73B EUR
Avg Volume
128.21K
P/E ratio
19.49
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 199.14M | -15.13% |
Operating expense | 76.04M | 19.96% |
Net income | 23.39M | -54.59% |
Net profit margin | 11.75 | -46.47% |
Earnings per share | — | — |
EBITDA | 32.69M | -51.18% |
Effective tax rate | 27.34% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 28.02M | 10.15% |
Total assets | 832.02M | 4.02% |
Total liabilities | 250.48M | -2.30% |
Total equity | 581.54M | — |
Shares outstanding | 51.15M | — |
Price to book | 4.76 | — |
Return on assets | 9.47% | — |
Return on capital | 11.71% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2024info | Y/Y change |
---|---|---|
Net income | 23.39M | -54.59% |
Cash from operations | 73.12M | 19.82% |
Cash from investing | -47.17M | -79.50% |
Cash from financing | -16.32M | 75.20% |
Net change in cash | 9.63M | 131.02% |
Free cash flow | 18.84M | -17.14% |
About
Founded
1946
Website
Employees
2,197